Atlas Trials

Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC)

Clinical trial NCT07076693 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07076693
Sponsor
Shanghai Chest Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
OligoProgressive Metastatic DiseaseNon-Small Cell Lung Cancer
Start date
2025-06-03
Primary completion
2028-05-31
Enrollment
97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.